Suvretta Capital Management, LLC Eye Point Pharmaceuticals, Inc. Transaction History
Suvretta Capital Management, LLC
- $2.39 Billion
- Q2 2024
A detailed history of Suvretta Capital Management, LLC transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Suvretta Capital Management, LLC holds 5,175,823 shares of EYPT stock, worth $62.7 Million. This represents 1.88% of its overall portfolio holdings.
Number of Shares
5,175,823
Previous 3,763,888
37.51%
Holding current value
$62.7 Million
Previous $77.8 Million
42.12%
% of portfolio
1.88%
Previous 3.33%
Shares
14 transactions
Others Institutions Holding EYPT
# of Institutions
163Shares Held
58.2MCall Options Held
224KPut Options Held
1.41M-
Cormorant Asset Management, LP Boston, MA8.33MShares$101 Million5.57% of portfolio
-
Black Rock Inc. New York, NY3.76MShares$45.6 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA3.65MShares$44.2 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.59MShares$43.5 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.77MShares$33.6 Million0.0% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $413M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...